Vaccinex Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017	2016
Revenue	0.57	0.28	0.9	0.63	0.52	0.72	0.09	0.32
Revenue Growth (YoY)	107.27%	-69.44%	44.00%	19.50%	-27.76%	704.44%	-71.52%	-
Cost of Revenue	0	0	0	0	0.2	1.03	0.16	0.12
Gross Profit	0.57	0.28	0.9	0.62	0.32	-0.31	-0.07	0.2
Selling, General & Admin	6.88	6.2	6.23	7.41	6.67	4.62	4.48	4.43
Research & Development	16.57	13.98	17.16	21.55	25.67	22.35	16.55	16.03
Operating Expenses	23.46	20.18	23.39	28.95	32.34	26.97	21.03	20.46
Operating Income	-22.89	-19.91	-22.49	-28.33	-32.02	-27.28	-21.1	-20.26
Interest Expense / Income	0	0	0.81	0.49	0	0.39	1.36	2.99
Other Expense / Income	-2.64	-0.09	-0.92	0.03	-0.15	1.85	-3.74	-9.31
Pretax Income	-20.25	-19.82	-22.38	-28.85	-31.86	-29.52	-18.72	-13.94
Net Income	-20.25	-19.82	-22.38	-28.85	-31.86	-29.52	-18.72	-13.94
Preferred Dividends	0	0	0	0	0	0	3.21	12.29
Net Income Common	-20.25	-19.82	-22.38	-28.85	-31.86	-29.52	-21.93	-26.23
Shares Outstanding (Basic)	0	0	0	0	0	0	0	0
Shares Outstanding (Diluted)	0	0	0	0	0	0	0	0
Shares Change	129.44%	47.10%	53.56%	45.85%	146.59%	374.06%	6.13%	-
EPS (Basic)	-43.68	-98.05	-163.80	-323.40	-518.70	-1186.50	-4179.00	-5306.70
EPS (Diluted)	-43.68	-98.05	-163.80	-323.40	-518.70	-1186.50	-4179.00	-5306.70
Free Cash Flow	-17.3	-19.17	-25.33	-28.94	-30.79	-25.51	-21.46	-20.51
Free Cash Flow Per Share	-37.31	-94.88	-184.38	-323.46	-502.03	-1025.59	-4088.76	-4149.47
Gross Margin	100.00%	100.00%	100.00%	99.68%	61.95%	-42.68%	-77.78%	63.61%
Operating Margin	-4014.91%	-7238.55%	-2498.89%	-4532.96%	-6121.41%	-3768.09%	-23448.89%	-6411.08%
Profit Margin	-3552.81%	-7205.45%	-2486.67%	-4616.16%	-6092.35%	-4077.07%	-24370.00%	-8301.58%
Free Cash Flow Margin	-3035.26%	-6972.00%	-2814.44%	-4629.92%	-5887.76%	-3523.62%	-23838.89%	-6491.46%
EBITDA	-20.13	-19.61	-21.4	-28.06	-31.61	-28.9	-17.16	-10.78
EBITDA Margin	-3531.75%	-7129.45%	-2378.00%	-4488.80%	-6044.74%	-3992.13%	-19064.44%	-3409.81%
Depreciation & Amortization	0.12	0.21	0.17	0.31	0.25	0.22	0.21	0.18
EBIT	-20.25	-19.81	-21.57	-28.36	-31.86	-29.13	-17.36	-10.95
EBIT Margin	-3552.63%	-7204.73%	-2396.78%	-4537.92%	-6092.35%	-4022.93%	-19293.33%	-3466.14%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).